miR-126 downregulates epidermal growth factor-like domain multiple 7 (EGFL7), a tumor-suppressor in OSCC, thereby regulating vascular endothelial growth factor (VEGF), Notch, and Wnt signaling pathways. Here, LRP4 is linked to neoplasm.